Tadalafil prevents acute heart failure with reduced ejection fraction in mice (Q45004611)

8 December 2017

title

Tadalafil prevents acute heart failure with reduced ejection fraction in mice (English)

1 reference

heart failure with reduced ejection fraction

8 December 2017

0 references

1 reference

1 reference

acute decompensated heart failure

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25322707 AND SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Fadi N Salloum

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25322707 AND SRC:MED&resulttype=core&format=json

6 June 2020

Nicholas N Hoke

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25322707 AND SRC:MED&resulttype=core&format=json

6 June 2020

Rakesh C Kukreja

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25322707 AND SRC:MED&resulttype=core&format=json

6 June 2020

publication date

1 December 2014

1 reference

Cardiovascular Drugs and Therapy

8 December 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25322707 AND SRC:MED&resulttype=core&format=json

6 June 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25322707 AND SRC:MED&resulttype=core&format=json

6 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25322707 AND SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

493-500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25322707 AND SRC:MED&resulttype=core&format=json

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Cyclic GMP-dependent protein kinase Ialpha attenuates necrosis and apoptosis following ischemia/reoxygenation in adult cardiomyocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Sildenafil citrate (viagra) induces cardioprotective effects after ischemia/reperfusion injury in infant rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

The Discovery of Tadalafil: A Novel and Highly Selective PDE5 Inhibitor. 1: 5,6,11,11a-Tetrahydro-1H-imidazo[1‘,5‘:1,6]pyrido[3,4-b]indole-1,3(2H)-dione Analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Tadalafil for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24 h after oral administration in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Gene Therapy With Inducible Nitric Oxide Synthase Protects Against Myocardial Infarction via a Cyclooxygenase-2–Dependent Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Death by design. Programmed cell death in cardiovascular biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

TGF-β mediates early angiogenesis and latent fibrosis in an Emilin1-deficient mouse model of aortic valve disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Phosphodiesterase inhibitors, congestive heart failure, and sudden death: time for re-evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10557-014-6559-0

10.1007/S10557-014-6559-0

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25322707 AND SRC:MED&resulttype=core&format=json

6 June 2020

1 reference